THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY

THE PROBLEM OF THE USE OF NEW ORAL ANTICOAGULANTS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY

Show other versions (1)

Despite large number of known risk factors of venous thromboembolism (VTE) in cancer patients existing prediction models do not allow definite identification of cancer patients that have indications for anticoagulant prevention. Besides, heparin and warfarin use for VTE prevention in cancer is accom...

Full description

Bibliographic Details
Main Authors: A. A. Rumyantsev, I. A. Pokataev, T. V. Kozlov, N. A. Rumyantsev
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
thrombosis
venous thromboembolism
cancer
oncology
new oral anticoagulants
Online Access:https://www.rpcardio.com/jour/article/view/300

Internet

https://www.rpcardio.com/jour/article/view/300

Similar Items